TABLE 1.

Study eligibility criteria.

	Inclusion	Exclusion
Population	Adult (≥18 years) cancer survivors who had completed curatively intended cancer treatment with experience of PIFU or expressing a view on PIFU. Carers/family members of such cancer survivors. HCPs with experience of PIFU or expressing a view on PIFU. Any type of cancer.	Patients with active disease undergoing treatment. Children.
Follow‐up strategy	Any type of FU strategy for recurrence (first or subsequent) providing it includes a form of PIFU. PIFU as the only or main component of a follow‐up strategy, or as an adjunct to standard follow‐up.	Any other follow‐up models that do not include an element of PIFU.
Study design	Qualitative studies, or the qualitative component from mixed methods studies, with a focus on follow‐up strategies and which provide data on PIFU. No restrictions on setting or type of data collection No restriction on reporting, e.g. full report or conference abstract only. Quantitative surveys eliciting views on acceptability and/or preferences related to PIFU.	Studies with no primary data and single case reports.
Outcomes	Patients' (or carers'/family members' or HCP's) views, opinions, experiences, behaviours and preferences relating to PIFU.	Effectiveness or cost‐effectiveness of PIFU.